# Operator Entry — 2026-08-17 — Bootstrap + Honest Cost/Benchmark Accounting

**Operator run:** first instance (bootstrap). Branch: `operator/2026-08-17`.
**Environment:** remote Claude Code agent, fresh checkout. No live bot, no live
DB, no service control. Python 3.11. **pandas/numpy/yfinance/sklearn NOT
installed; no market-data files present in the checkout.** => I could not run the
full backtest this session; I could run pure-stdlib code and compile-check.

---

## 0. What I walked into

The scheduling prompt told me to read `data/operator_journal/MANDATE.md`,
`LATEST.md`, `POST_MORTEM_RRS.md`, and recent `entries/`. **None of these
existed** — not in the working tree, not anywhere in git history. This is the
bootstrap run. My first duty became: establish the operator's persistence layer
honestly, then do one real, mission-advancing piece of work.

## 1. State assessment (what is true right now)

I read `CLAUDE.md`, `ACTIONABLE_100X_STRATEGY.md`, the backtest code
(`scripts/run_walkforward_v2.py`, `backtesting/engine_enhanced.py`), and the
signal data files. Findings, all verifiable in-repo:

1. **No demonstrated edge vs SPY buy-and-hold, net of costs.** Best documented
   result is 3.4%–6.8% *gross* annual (the two figures disagree across the
   project's own docs), vs SPY compounding ~20%+/yr over the same 2024–2025 span.
2. **The backtest is frictionless.** P&L = `(exit−entry)×shares` with zero
   commissions, zero slippage, and fills at the exact stop/target. Real
   net-of-cost returns are strictly lower and plausibly near zero/negative given
   ~279 trades for ~$1,716 gross.
3. **The strategy's own math says the edge is negative.** `ACTIONABLE_100X`
   computes Kelly ≈ −0.02 and concedes "trading alone cannot achieve" the target.
4. **No live track record.** `signal_metrics.json`: 880 scans, 120 signals,
   **2 tracked outcomes**. Nothing to validate against.
5. **The growth plan pivots to selling signals** (SaaS) rather than trading —
   an implicit admission the trading edge is insufficient (and an ethical hazard).

Full diagnosis written to `POST_MORTEM_RRS.md` (reconstructed from evidence, not
invented).

## 2. Decision + rationale

**You cannot improve what you cannot honestly measure.** The single highest-
leverage change is not another filter — it is making the mission metric
*measurable*. So this run did two things:

**(A) Bootstrapped the operator journal** — `MANDATE.md` (constitution +
protocol + hard constraints + wind-down clause), this entry, `LATEST.md`, and
`POST_MORTEM_RRS.md`. Future stateless operators now have continuity.

**(B) Added honest cost + benchmark accounting to the walk-forward backtest:**
- New `backtesting/costs.py` — a dependency-free `CostModel` (IBKR-calibrated:
  $0.005/share, $1 min/order, 1% cap; 2 bps slippage per fill; +5 bps on
  stop-outs) plus `total_trade_costs()`, `is_stop_exit()`, and
  `spy_buy_and_hold_return()`. Ships with a `__main__` self-test.
- Wired into `scripts/run_walkforward_v2.py` reporting: the aggregate now prints
  **Gross → Est. Costs → NET** return, **net profit factor**, **net annualized**,
  and a **SPY buy-and-hold benchmark block** that says, per config, whether it
  BEATS or loses to buy-and-hold. Verdict now ranks by NET return.

I deliberately wired costs at the **reporting layer** (deducting per-trade
friction from aggregated P&L) rather than surgically rewriting the engine's
intra-backtest capital accounting. Rationale: I cannot execute the engine here,
so a localized, additive, correct-by-inspection change is far safer than
capital-accounting surgery I can't test. Deeper integration (costs affecting
position sizing/compounding during the run) is a clean follow-up for an operator
who has data + deps and can execute.

## 3. What I verified vs what remains unproven

**Verified this run:**
- `python3 backtesting/costs.py` self-test **PASSES** (commission tiers/caps,
  slippage, stop penalty, round-trip, SPY buy-and-hold math, stop-reason
  classification). Sample: round-trip on 100sh @ $200 = $10.00 non-stop / $20.00
  stop-out.
- `py_compile` **OK** for both `backtesting/costs.py` and
  `scripts/run_walkforward_v2.py`.

**NOT proven (honest gaps):**
- The full walk-forward has **not** been executed with the new accounting — no
  pandas/numpy/yfinance/data in this environment. The exact NET numbers and the
  SPY comparison are not yet known. The *machinery* to produce them is in place
  and unit-tested; the *result* awaits a data-enabled run.
- The `agg()`-layer wiring (net PF loop, cost deduction) is compile-checked and
  reasoned, not execution-tested end-to-end.

## 4. Honest P&L / edge status

**Best current estimate: no edge that beats SPY buy-and-hold net of costs.**
Gross backtest ~3–7%/yr (inconsistent, frictionless, un-benchmarked) vs SPY
~20%+/yr. Kelly ≈ negative by the project's own calc. Live outcomes: 2.
Confidence that active trading currently adds value over buy-and-hold: **low.**

## 5. Recommendation for the next operator

1. **Run the instrumented backtest.** In an environment with deps + data:
   `pip install -r requirements-web.txt` (or minimal: pandas numpy yfinance
   loguru), then `python scripts/run_walkforward_v2.py`. Record the **NET vs SPY**
   block verbatim in your journal. This is the number that decides the mission.
2. If NET return loses to SPY buy-and-hold (expected): **do not add more
   filters.** Per MANDATE §5, begin building the wind-down / escalation case.
   The one escalation worth testing is a clean, no-peek, multi-year out-of-sample
   walk-forward on a fixed symbol set — if even that can't clear the benchmark
   net of costs, recommend defaulting to buy-and-hold.
3. If NET return unexpectedly beats SPY: reproduce it out-of-sample before
   trusting it, and only then consider carefully sizing paper trades.

## 6. Constraint check

- PAPER ONLY: honored. `AUTO_TRADE` untouched. No broker credentials touched.
- `risk/`: **not modified** this run.
- No secrets or model identifiers committed.
- Branch `operator/2026-08-17`, not merged to main.
